Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulation
- 1 August 2005
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 289 (2), L261-L267
- https://doi.org/10.1152/ajplung.00315.2004
Abstract
Mechanisms that maintain high pulmonary vascular resistance (PVR) and oppose vasodilation in the fetal lung are poorly understood. In fetal lambs, increased pulmonary artery pressure evokes a potent vasoconstriction, suggesting that a myogenic response contributes to high PVR in the fetus. In adult systemic circulations, the arachidonic acid metabolite 20-hydroxyeicosatetraenoic acid (20-HETE) has been shown to modulate the myogenic response, but its role in the fetal lung is unknown. We hypothesized that acute increases in pulmonary artery pressure release 20-HETE, which causes vasoconstriction, or a myogenic response, in the fetal lung. To address this hypothesis, we studied the hemodynamic effects of N-methylsufonyl-12,12-dibromododec-11-enamide (DDMS), a specific inhibitor of 20-HETE production, on the pulmonary vasoconstriction caused by acute compression of the ductus arteriosus (DA) in chronically prepared fetal sheep. An inflatable vascular occluder around the DA was used to increase pulmonary artery pressure under three study conditions: control, after pretreatment with nitro-l-arginine (l-NA; to inhibit shear-stress vasodilation), and after combined treatment with both l-NA and a specific 20-HETE inhibitor, DDMS. We found that DA compression after l-NA treatment increased PVR by 44 ± 12%. Although intrapulmonary DDMS infusion did not affect basal PVR, DDMS completely abolished the vasoconstrictor response to DA compression in the presence of l-NA (44 ± 12% vs. 2 ± 4% change in PVR, l-NA vs. l-NA + DDMS, P < 0.05). We conclude that 20-HETE mediates the myogenic response in the fetal pulmonary circulation and speculate that pharmacological inhibition of 20-HETE might have a therapeutic role in neonatal conditions characterized by pulmonary hypertension.Keywords
This publication has 31 references indexed in Scilit:
- Role of 20-hydroxyeicosatetraenoic acid in the renal and vasoconstrictor actions of angiotensin IIAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2002
- Contribution of 20-HETE to Vasodilator Actions of Nitric Oxide in the Cerebral MicrocirculationStroke, 1999
- Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteriesAmerican Journal of Physiology-Renal Physiology, 1998
- Human pulmonary arteries dilate to 20-HETE, an endogenous eicosanoid of lung tissue.American Journal of Physiology-Lung Cellular and Molecular Physiology, 1997
- Inhibition of 20-HETE Production Contributes to the Vascular Responses to Nitric OxideHypertension, 1997
- Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birthAmerican Journal of Physiology-Heart and Circulatory Physiology, 1990
- Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulationAmerican Journal of Physiology-Heart and Circulatory Physiology, 1989
- Temporal Response of the Fetal Pulmonary Circulation to Pharmacologic VasodilatorsExperimental Biology and Medicine, 1988
- Evidence of myogenic vascular control in the rat cerebral cortex.Circulation Research, 1984
- The vascular resistance of the foetal and newly ventilated lung of the lambThe Journal of Physiology, 1964